MAXIMILIAN MUENKE
Medical Practice in Cynwyd, PA
License number
Pennsylvania PAK000079
Category
Medicine
Type
Physician Acupuncturist
Address
Address
Cynwyd, PA 19004
Personal information
See more information about MAXIMILIAN MUENKE at radaris.comName
Address
Phone
Merion Station, PA
329 Bryn Mawr Ave, Bala Cynwyd, PA 19004
329 Bryn Mawr Ave, Ardmore, PA 19003
329 Bryn Mawr Ave, Merion, PA 19004
Organization information
See more information about MAXIMILIAN MUENKE at bizstanding.comMaximilian Muenke MD,DABMA
329 Bryn Mawr Ave, Bala Cynwyd, PA 19004
Industry:
Genetic Medicine
Phone:
(610) 256-4103 (Phone)
Maximilian Muenke
Professional information
Methods For Detecting And Treating Attention-Deficit/Hyperactivity Disorder
US Patent:
2010004, Feb 18, 2010
Filed:
Sep 27, 2007
Appl. No.:
12/444898
Inventors:
Maximilian Muenke - Bala Cynwyd PA, US
F. Xavier Castellanos - New York NY, US
F. Xavier Castellanos - New York NY, US
Assignee:
The United States of America, as represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
International Classification:
A61K 39/395, C12Q 1/68, C12P 19/34, A61K 38/02, A61P 25/00
US Classification:
4241411, 435 6, 435 912, 514 2, 4241301
Abstract:
The invention provides a method of determining a susceptibility of a subject for development of ADHD. The method comprises obtaining a sample from the subject, analyzing the sample for an ADHD susceptibility haplotype of LPHN3 receptor which is associated with at least one genetic marker selected from the group consisting of rs7678046, rs1901223, rs6813183, and rs1355368, and determining if the subject has a susceptibility to develop ADHD, whereby the presence of the haplotype having one or more of the genetic markers is indicative of a susceptibility to develop ADHD. The invention also provides methods of treating ADHD.
Methods For Detecting Adhd Susceptibility And Predicting Severity And Long Term Outcome Of Adhd Symptoms
US Patent:
2013001, Jan 10, 2013
Filed:
May 18, 2012
Appl. No.:
13/475342
Inventors:
Maximilian Muenke - Bala Cynwyd PA, US
Mauricio Arcos-Burgos - Canberra, AU
Maria Teresa Acosta - Bethesda MD, US
Mauricio Arcos-Burgos - Canberra, AU
Maria Teresa Acosta - Bethesda MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Ser. - Bethesda MD
International Classification:
C40B 30/04, A61K 31/519, A61K 31/165, C12Q 1/68, A61K 31/55, A61K 31/135, A61P 25/26, A61P 25/24, A61K 31/4168, A61K 31/137
US Classification:
514217, 514398, 51425941, 514618, 514654, 514656, 506 9, 435 611
Abstract:
The invention provides methods of determining an altered susceptibility to develop ADHD, methods of predicting or determining the severity of symptoms of ADHD and associated disorders, and methods of treatment based on the presence or absence of one or more alleles of single nucleotide polymorphism (SNP) markers.